In June, Genzyme will consolidate all three divisions by eliminating the tracking stocks for Molecular Oncology and Biosurgery.

FORBES: Magazine Article

Genzyme Molecular Oncology, a division of Genzyme General, of Cambridge, Mass.

FORBES: In search of antigens

Besides Genzyme General, the gene therapy program is involved in Genzyme Molecular Oncology gzmo (nasdaq: gzmo - news - people), which focuses on cancer vaccines, and Genzyme Surgical Products gzsp (nasdaq: gzsp - news - people).

FORBES: Genzyme Takes Gamble On Gene Therapy